Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2001 2
2002 2
2003 3
2004 5
2005 5
2006 1
2007 1
2008 1
2009 4
2010 3
2011 5
2012 3
2013 1
2015 3
2016 8
2017 3
2018 3
2019 4
2020 1
2021 1
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group. Feagan BG, et al. N Engl J Med. 2016 Nov 17;375(20):1946-1960. doi: 10.1056/NEJMoa1602773. N Engl J Med. 2016. PMID: 27959607 Free article. Clinical Trial.
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.
Feagan BG, Sands BE, Sandborn WJ, Germinaro M, Vetter M, Shao J, Sheng S, Johanns J, Panés J; VEGA Study Group. Feagan BG, et al. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):307-320. doi: 10.1016/S2468-1253(22)00427-7. Epub 2023 Feb 1. Lancet Gastroenterol Hepatol. 2023. PMID: 36738762 Clinical Trial.
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group. Holman RR, et al. N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14. N Engl J Med. 2017. PMID: 28910237 Free PMC article. Clinical Trial.
[The diabetic foot].
Lechleitner M, Abrahamian H, Francesconi C, Sturm W, Köhler G. Lechleitner M, et al. Among authors: francesconi c. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S80-4. doi: 10.1007/s00508-015-0928-y. Wien Klin Wochenschr. 2016. PMID: 27052225 Review. German.
PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
Huelsmann M, Neuhold S, Resl M, Strunk G, Brath H, Francesconi C, Adlbrecht C, Prager R, Luger A, Pacher R, Clodi M. Huelsmann M, et al. Among authors: francesconi c. J Am Coll Cardiol. 2013 Oct 8;62(15):1365-72. doi: 10.1016/j.jacc.2013.05.069. Epub 2013 Jun 27. J Am Coll Cardiol. 2013. PMID: 23810874 Free article. Clinical Trial.
43. Jahrestagung der Österreichischen Diabetes Gesellschaft.
Wascher TC, Francesconi C. Wascher TC, et al. Among authors: francesconi c. Wien Klin Wochenschr. 2015 Nov;127 Suppl 4:131-62. doi: 10.1007/s00508-015-0883-7. Wien Klin Wochenschr. 2015. PMID: 26542128 German. No abstract available.
[Diabetic neuropathy].
Lechleitner M, Abrahamian H, Francesconi C, Kofler M. Lechleitner M, et al. Among authors: francesconi c. Wien Klin Wochenschr. 2016 Apr;128 Suppl 2:S73-9. doi: 10.1007/s00508-015-0930-4. Wien Klin Wochenschr. 2016. PMID: 27052228 Review. German.
[Diabetic neuropathy and diabetic foot syndrome (Update 2019)].
Lechleitner M, Abrahamian H, Francesconi C, Kofler M, Sturm W, Köhler G. Lechleitner M, et al. Among authors: francesconi c. Wien Klin Wochenschr. 2019 May;131(Suppl 1):141-150. doi: 10.1007/s00508-019-1487-4. Wien Klin Wochenschr. 2019. PMID: 30980143 Review. German.
[Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S. Lechleitner M, et al. Among authors: francesconi c. Wien Klin Wochenschr. 2019 May;131(Suppl 1):39-46. doi: 10.1007/s00508-019-1492-7. Wien Klin Wochenschr. 2019. PMID: 30980147 Free article. Review. German.
69 results